FORMULATION, DEVELOPMENT AND EVALTUATION OF APREMILAST IMMEDIATE RELEASE TABLET FOR MANAGMENT OF PSORIATIC ARTHRITIS

FORMULATION, DEVELOPMENT AND EVALTUATION OF APREMILAST IMMEDIATE RELEASE TABLET FOR MANAGMENT OF PSORIATIC ARTHRITIS

Registration ID: IJNRD_197500

Published ID: IJNRDTH00050

DOI: Click Here to Get

PRIYANKA SUSHILKUMAR SARNIKAR , HINGNE L.D , BAGWAN LATIF RASHID

ABSTRACT: The aim of this research paper was to develop and evaluate an Apremilast immediate release tablet for the management of Psoriatic Arthritis by utilizing excipients and checking their compatibility with the API through preformulation studies. The tablets were formed using the direct compression method, and different trial batches were performed to check their activity.The preformulation studies showed that the selected excipients were compatible with the API, and the optimized formulation was found to have good flow and compressibility properties. The tablets were evaluated for their physical characteristics, including size, weight, and hardness. The in vitro dissolution studies were also conducted to assess the drug release profile of the developed tablets.The results of the study showed that the developed Apremilast immediate release tablets had excellent physical characteristics, with uniform size and weight. The in vitro dissolution studies indicated that the tablets had a quick release rate and met the required pharmacopoeial standards. The pharmacokinetic study revealed that the tablets exhibited rapid absorption, with a maximum plasma concentration achieved within 1 hour of administration.In conclusion, the developed Apremilast immediate release tablet utilizing excipients and preformulation studies has the potential to be an effective therapeutic option for the management of Psoriatic Arthritis. Further studies are required to investigate. Sometimes immediate onset of action is considered obligatory immediate release tablets are the final option. Recently immediate release tablets have started gaining popularity and acceptance as a drug delivery system, mainly because they are easy to administer and lead to better patient compliance. In the present work, we engage in discussion about formulation, development, and evaluation of immediate release tablets. An immediate release dosage form allows a manufacturer to extend market exclusivity. They are also a tool for expanding markets, extending product life cycles and generating opportunities. Pharmaceutical products designed for oral delivery and currently available on the prescription and over-the-counter markets are mostly the immediate release tablet.

Published Paper   E-Certificate

"FORMULATION, DEVELOPMENT AND EVALTUATION OF APREMILAST IMMEDIATE RELEASE TABLET FOR MANAGMENT OF PSORIATIC ARTHRITIS", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.8, Issue 6, page no.773-816, June-2023, Available :https://ijnrd.org/papers/IJNRDTH00050.pdf

Volume 8 Issue 6, June-2023

Pages : 773-816

Paper Reg. ID: IJNRD_197500

Published Paper Id: IJNRDTH00050

Downloads: 000121155

Research Area: Pharmacy

Country: Beed, Maharashtra , India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00050.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00050

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area